Dermata Therapeutics, Inc. (DRMA) has 4 open-market insider trades by 3 insiders since 2021. Over the last six months insiders net sold $13. The most active filer is Gerald T. Proehl, CEO & Chairman +2.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Gerald T. Proehl | CEOChairmanPres10% Owner | — | 2 | $98K | 2026-08-16 |
| Munera Maria E. Bedoya-Toro | VP | — | 1 | $1K | 2026-02-17 |
| Kathleen D. Scott | Dir | — | 1 | $13 | 2026-06-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Kathleen D. Scott | Director | Sell | $13 | 2026-06-16 |
| Munera Maria E. Bedoya-Toro | VP | Buy | $1K | 2026-02-17 |
| Gerald T. Proehl | Chairman & President +1 | Buy | $48K | 2021-11-23 |
| Gerald T. Proehl | Chairman & President +1 | Buy | $50K | 2021-08-16 |
Companies that share insiders with DRMA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.